patent expiry for GLP-1 drugs across markets Company Molecule Brand Name Mode of administration First US Patent Expiry Canada Brazil India Novo Semaglutide Ozempic Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Wegovy Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Rybelsus Oral 2031 Jan 2026 Mar 2026 Mar 2026 Eli Lilly Tirzepatide Mounjaro Injectable 2036 2036 2036 2036 Eli Lilly Tirzepatide Zepbound Injectable 2036 2036 2036 2036 Positioning of Indian Pharma companies in GLP-1s company positioning Shaily Engineering Leading manufacturer of pen injectors for GLP-1 therapies
Other key agents in this class are dulaglutide and the novel dual GIP/GLP-1 receptor agonist, tirzepatide [16,17,18,19]
The Power Blendz Nutrition team has invested many years into research, testing & development, before releasing L-Carnitine Plus to the public
Nonetheless, Shafipour said some people prefer the injection because they only have to administer a treatment once a week
It is only available for research purposes and should only be used in experimental conditions
Experts commonly recommend about 1.2 to 1.6 g of protein per kilogram of body weight per day for supporting muscle mass
